ArticleMolecular biology reports2025
Conditioned medium from adipose mesenchymal stromal cells stimulated with pituitary adenylate cyclase-activating polypeptide (PACAP) mitigates RINm5F pancreatic β-cell dysfunction.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe regenerative potential of mesenchymal stromal cells (MSCs) is linked to their secretion of bioactive molecules that modulate cellular processes. Different immunomodulatory molecules enhance their secretory and functional capacity. PACAP reduces oxidative stress and apoptosis, while promoting proliferation and cell differentiation. It also regulates inflammation and the immune response, but its role in MSCs secretoma modulation remains poorly explored. This study aimed to evaluate the effect of conditioned medium (CM) derived from PACAP -preconditioned MSCs on the recovery of β-pancreatic cells from the RINm5F line exposed to oxidative damage. METHODS AND
resultsMSCs were obtained from adipose tissue of Sprague-Dawley rats. The concentration of PACAP to stimulate MSCs viability was determined by MTT assay. The mitochondrial metabolism of MSCs was significantly increased by PACAP at 0.1nM for 48 h. We evaluated the resulting CM protective effect in RINm5F cells exposed to oxidative damage by high glucose and streptozotocin (STZ). A dose-response curve was previously performed to select the CM concentration. Viability, mitochondrial membrane potential (MMP), radical oxygen species (ROS), apoptosis, glutathione peroxidase (GPx) activity and insulin secretion were all evaluated. RINm5F β-pancreatic cells treated with PACAP-preconditioned MSCs CM increased cells viability, restored MMP, reduced ROS and apoptosis caused by oxidative stress. In addition, we observed an increase in GPx antioxidant activity, and functional recovery of these cells was confirmed by increased insulin levels.
conclusionsCM from PACAP-MSCs reverses oxidative damage and apoptosis of RINm5F-pancreatic B cells caused by high glucose and STZ, probably by stimulating their antioxidant response, without ruling out other compensatory mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.